Comparative effectiveness research on patients with acute ischemic stroke using Markov decision processes
- PMID: 22400712
- PMCID: PMC3348070
- DOI: 10.1186/1471-2288-12-23
Comparative effectiveness research on patients with acute ischemic stroke using Markov decision processes
Abstract
Background: Several methodological issues with non-randomized comparative clinical studies have been raised, one of which is whether the methods used can adequately identify uncertainties that evolve dynamically with time in real-world systems. The objective of this study is to compare the effectiveness of different combinations of Traditional Chinese Medicine (TCM) treatments and combinations of TCM and Western medicine interventions in patients with acute ischemic stroke (AIS) by using Markov decision process (MDP) theory. MDP theory appears to be a promising new method for use in comparative effectiveness research.
Methods: The electronic health records (EHR) of patients with AIS hospitalized at the 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine between May 2005 and July 2008 were collected. Each record was portioned into two "state-action-reward" stages divided by three time points: the first, third, and last day of hospital stay. We used the well-developed optimality technique in MDP theory with the finite horizon criterion to make the dynamic comparison of different treatment combinations.
Results: A total of 1504 records with a primary diagnosis of AIS were identified. Only states with more than 10 (including 10) patients' information were included, which gave 960 records to be enrolled in the MDP model. Optimal combinations were obtained for 30 types of patient condition.
Conclusion: MDP theory makes it possible to dynamically compare the effectiveness of different combinations of treatments. However, the optimal interventions obtained by the MDP theory here require further validation in clinical practice. Further exploratory studies with MDP theory in other areas in which complex interventions are common would be worthwhile.
Similar articles
-
Comparative Effectiveness of Different Combinations of Treatment Interventions in Patients with Stroke at the Convalescence Stage Based on the Markov Decision Process.Evid Based Complement Alternat Med. 2020 May 12;2020:8961341. doi: 10.1155/2020/8961341. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32454873 Free PMC article.
-
Chinese acute ischemic stroke treatment outcome registry (CASTOR): protocol for a prospective registry study on patterns of real-world treatment of acute ischemic stroke in China.BMC Complement Altern Med. 2017 Jul 6;17(1):357. doi: 10.1186/s12906-017-1863-4. BMC Complement Altern Med. 2017. PMID: 28683732 Free PMC article.
-
[Exploring Chinese medicine and Western medicine group modules in acute phase of ischemic stroke disease].Zhongguo Zhong Yao Za Zhi. 2018 Feb;43(3):618-626. doi: 10.19540/j.cnki.cjcmm.20171211.001. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 29600631 Chinese.
-
Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials.Health Qual Life Outcomes. 2021 Mar 9;19(1):79. doi: 10.1186/s12955-021-01728-6. Health Qual Life Outcomes. 2021. PMID: 33750396 Free PMC article. Review.
-
The fundamental theory of traditional Chinese medicine and the consideration in its research strategy.Front Med. 2011 Jun;5(2):208-11. doi: 10.1007/s11684-011-0126-x. Epub 2011 Jun 22. Front Med. 2011. PMID: 21695627 Review.
Cited by
-
Comparative Effectiveness of Different Combinations of Treatment Interventions in Patients with Stroke at the Convalescence Stage Based on the Markov Decision Process.Evid Based Complement Alternat Med. 2020 May 12;2020:8961341. doi: 10.1155/2020/8961341. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32454873 Free PMC article.
-
A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process.Pharmacoeconomics. 2022 Nov;40(11):1015-1032. doi: 10.1007/s40273-022-01185-z. Epub 2022 Sep 14. Pharmacoeconomics. 2022. PMID: 36100825 Free PMC article. Review.
-
What can comparative effectiveness research, propensity score and registry study bring to Chinese medicine?Chin J Integr Med. 2014 Oct;20(10):792-5. doi: 10.1007/s11655-013-1662-9. Epub 2014 Mar 7. Chin J Integr Med. 2014. PMID: 24615256
References
-
- IOM. Initial National Priorities for Comparative Effectiveness Research [cited 2011, March 1] http://www.iom.edu/~/media/Files/Report%20Files/2009/ComparativeEffectiv...
-
- Concato J, Peduzzi P, Huang GD, O'Leary TJ, Kupersmith J. Comparative effectiveness research: what kind of studies do we need? J Investig Med. 2010;5(8):764–769. - PubMed
-
- Lohr KN. Comparative effectiveness research methods: symposium overview and summary. Med Care. 2010;48(6 suppl):S3–S6. - PubMed
-
- Crown WHO, Obenchain RL, Englehart L, Lair T, Buesching DP, Croghan T. The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilization. Stat Med. 1998;17(17):1943–1958. doi: 10.1002/(SICI)1097-0258(19980915)17:17<1943::AID-SIM885>3.0.CO;2-0. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical